Metraipolis › archive › dc_fb9faf349e9d

Optimizing drug combinations to resurrect the potency of failed antibody therapy against emerging COVID-19 variants using IDentif.AI — Europe PMC PMID:42311436

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42311436
DOI
10.3389/fdgth.2026.1744623
License (as archived)
solo-consultazione
Archived
2026-10-31T21:57:59.154Z
SHA-256 of the archived text
9942913c31f1fed0c65ef617a63c51ac69d067c4692a242397610eb509897ca3
Stable URL of this page
https://metraipolis.com/documento/dc_fb9faf349e9d

How to cite

Optimizing drug combinations to resurrect the potency of failed antibody therapy against emerging COVID-19 variants using IDentif.AI — Europe PMC PMID:42311436 — Europe PMC (en), https://europepmc.org/article/MED/42311436 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb9faf349e9d (Metraipolis archive dc_fb9faf349e9d, sha256 9942913c31f1fed0c65ef617a63c51ac69d067c4692a242397610eb509897ca3)
BibTeX
@misc{dcfb9faf349e9d,
  title = {Optimizing drug combinations to resurrect the potency of failed antibody therapy against emerging COVID-19 variants using IDentif.AI — Europe PMC PMID:42311436},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42311436},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb9faf349e9d; sha256 9942913c31f1fed0c65ef617a63c51ac69d067c4692a242397610eb509897ca3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42311436. Agents can read the archived copy with the MCP tool read_document.